Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...
A study published in The British Medical Journal that followed more than 20 lakh women in Denmark for more than 10 years ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception -- including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback